In the early 21st century the bioprocessing industry fretted about a production crisis that never happened. Concern arose a decade ago that downstream purification facilities would not be adequate to ...

One of the most important bioprocessing advances in recent years has been the rise in levels of manufactured therapeutic proteins. Indeed, the overall average yield reported for commercial monoclonal ...